N J Senff

Summary

Affiliation: Leiden University Medical Center
Country: The Netherlands

Publications

  1. ncbi Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers
    Nancy J Senff
    Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands
    J Clin Oncol 25:1581-7. 2007
  2. ncbi The applicability and prognostic value of the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: results on a large cohort of primary cutaneous B-cell lymphomas and comparison with the system us
    N J Senff
    Department of Dermatology, Leiden University Medical Centre, PO Box 9600, 2300 RC Leiden, The Netherlands
    Br J Dermatol 157:1205-11. 2007
  3. ncbi Results of radiotherapy in 153 primary cutaneous B-Cell lymphomas classified according to the WHO-EORTC classification
    Nancy J Senff
    Department of Dermatology, B1 Q, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands
    Arch Dermatol 143:1520-6. 2007
  4. ncbi Results of bone marrow examination in 275 patients with histological features that suggest an indolent type of cutaneous B-cell lymphoma
    Nancy J Senff
    Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands
    Br J Haematol 142:52-6. 2008
  5. ncbi Fine-mapping chromosomal loss at 9p21: correlation with prognosis in primary cutaneous diffuse large B-cell lymphoma, leg type
    Nancy J Senff
    Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands
    J Invest Dermatol 129:1149-55. 2009
  6. ncbi European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas
    Nancy J Senff
    Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands
    Blood 112:1600-9. 2008
  7. ncbi Low-dose palliative radiotherapy for cutaneous B- and T-cell lymphomas
    Karen J Neelis
    Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands
    Int J Radiat Oncol Biol Phys 74:154-8. 2009

Detail Information

Publications7

  1. ncbi Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers
    Nancy J Senff
    Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands
    J Clin Oncol 25:1581-7. 2007
    ..This study aimed to assess the clinical significance of the new classification compared with previous classification schemes (EORTC 1997; WHO 2001) and to define prognostic factors within the newly defined categories...
  2. ncbi The applicability and prognostic value of the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: results on a large cohort of primary cutaneous B-cell lymphomas and comparison with the system us
    N J Senff
    Department of Dermatology, Leiden University Medical Centre, PO Box 9600, 2300 RC Leiden, The Netherlands
    Br J Dermatol 157:1205-11. 2007
    ..The applicability and the prognostic significance of this system have not been investigated thus far...
  3. ncbi Results of radiotherapy in 153 primary cutaneous B-Cell lymphomas classified according to the WHO-EORTC classification
    Nancy J Senff
    Department of Dermatology, B1 Q, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands
    Arch Dermatol 143:1520-6. 2007
    ....
  4. ncbi Results of bone marrow examination in 275 patients with histological features that suggest an indolent type of cutaneous B-cell lymphoma
    Nancy J Senff
    Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands
    Br J Haematol 142:52-6. 2008
    ..001). These results indicate that bone marrow investigation is essential for staging patients with a FCL first presenting in the skin. Bone marrow examination appears to have limited value in patients with MZL presenting in the skin...
  5. ncbi Fine-mapping chromosomal loss at 9p21: correlation with prognosis in primary cutaneous diffuse large B-cell lymphoma, leg type
    Nancy J Senff
    Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands
    J Invest Dermatol 129:1149-55. 2009
    ..In most patients the deletion involves a large area of at least several kilobase pairs instead of a small minimal common region...
  6. ncbi European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas
    Nancy J Senff
    Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands
    Blood 112:1600-9. 2008
    ..They may therefore contribute to uniform staging and treatment and form the basis for future clinical trials in patients with a CBCL...
  7. ncbi Low-dose palliative radiotherapy for cutaneous B- and T-cell lymphomas
    Karen J Neelis
    Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands
    Int J Radiat Oncol Biol Phys 74:154-8. 2009
    ..To determine the efficacy of low-dose palliative radiotherapy for both low-grade malignant cutaneous B-cell lymphomas (CBCLs) and cutaneous T-cell lymphomas (mycosis fungoides)...